AUG 01, 2019 10:14 AM PDT

Novel Therapy Shows Promise for Acute Migraines

WRITTEN BY: Nouran Amin

In a study published in The New England Journal of Medicine, a novel drug, by the name of rimegepant, was found to eliminate pain and reduce characteristic symptoms of an acute migraine in comparison to over-the counter drugs. The study was carried out by Albert Einstein College of Medicine and Montefiore Health System for a large clinical trial and is now awaiting the approval of rimegepant by the U.S. Food and Drug Administration. "For the first time in nearly three decades, people with migraine not helped by existing medications may have a new option to find relief during attacks," says first author, Richard B. Lipton, M.D.

Migraines are debilitating and currently affect about 12 to 14% of people worldwide. It is neurologic disorder characterized by periodic attacks of head pain along with symptoms ranging from feelings of nausea to sensitivity from light and sound. Most sufferers experience at least one migraine attack per month with more than half left severely impaired during their attacks.

Presently, individuals with migraines likely take triptan medications that work to reduce inflammation and constrict blood vessels. These drugs are not beneficial to everyone and can cause intolerable side effect. However, with the novel drug rimegepant, it opens the door for effective and tolerable treatment options besides triptan. "These results confirm that rimegepant's mechanism of action -- blocking the CGRP pathway -- effectively relieves pain and associated symptoms that occur during acute migraine attacks," said Dr. Lipton. "As someone who has studied CGRP blockers for more than a decade, I'm gratified to see their benefits confirmed in a large-scale clinical trial."

Source: Albert Einstein College of Medicine

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 20, 2019
Drug Discovery & Development
NOV 20, 2019
Why Drugs that Work on Mice Don't Work on Humans
Mice are used as the frontline for drug testing for brain disorders. Why? Their brains are supposed to have much of the same functioning as ours. Moreover,...
NOV 20, 2019
Cardiology
NOV 20, 2019
Somethings Fishy With Omega 3 Claims
Each month nearly 20 million Americans turn to fish oil for heart disease prevention. Though it may sound healthy, this trend is troubling in the face of z...
NOV 20, 2019
Cancer
NOV 20, 2019
Cancer drugs don't work the way we thought
New research recently published in the journal Science Translational Medicine surprises the oncological community with findings that a protein previously t...
NOV 20, 2019
Drug Discovery & Development
NOV 20, 2019
Evolutionary-Busting Cancer Drug
Researchers at the Institute of Cancer Research in London have discovered that a new type of drug that blocks treatment in cancers. The drug works by inhib...
NOV 20, 2019
Drug Discovery & Development
NOV 20, 2019
Therapeutic To Treat The Detrimental Effects of Marijuana
As U.S. states continue to legalize the use of marijuana, so is the number of American women using cannabis before becoming pregnant and to treat morning s...
NOV 20, 2019
Drug Discovery & Development
NOV 20, 2019
Common Therapeutic Can Treat Bleeding Associated with Traumatic Brain Injury
An inexpensive and accessible drug was found to reduce rates of mortality associated with traumatic brain injury (TBI) patients by 20%. TBI is a major caus...
Loading Comments...